PPIDT00377
Drug Information
| Name | Cenegermin |
|---|---|
| Sequence | Not Available |
| DrugBank_ID | DB13926 |
| Type | biotech |
| Indication | Cenegermin is indicated for the treatment of moderate (persistent epithelial defect) or severe (corneal ulcer) neurotrophic keratitis in adults by the FDA and EMA.[L49056,L49051] |
Dosage Forms
| Form | Route | Strength |
|---|---|---|
| Kit; solution / drops | Ophthalmic |
20 ug/1mL
|
| Solution | Ophthalmic |
0.00002
|
| Solution / drops | Ophthalmic |
20 MCG/ML
|
| Solution / drops | Ophthalmic |
20 ug/1mL
|